Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Smith

Showing results (441-450 of 455) with videos related to

Pageof 46
Sort By:
ACS Medicinal Chemistry Letters|March 21, 2019
Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481Kenneth M Boy, Jason M Guernon, Dmitry S Zuev, et al.
Journal of Medicinal Chemistry|September 8, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic TherapyAndrew K Dilger, Kumar B Pabbisetty, James R Corte, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Plant Phenomics (Washington, D.C.)|November 15, 2021
Global Wheat Head Detection 2021: An Improved Dataset for Benchmarking Wheat Head Detection MethodsEtienne David, Mario Serouart, Daniel Smith, et al.
Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaTarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
Movement Ecology|April 23, 2024
From little things big things grow: enhancement of an acoustic telemetry network to monitor broad-scale movements of marine species along Australia's east coastAdam Barnett, Fabrice R A Jaine, Stacy L Bierwagen, et al.
Journal of Medicinal Chemistry|March 21, 2019
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)Scott H Watterson, Qingjie Liu, Myra Beaudoin Bertrand, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic DiseasesPeter T W Cheng, Robert F Kaltenbach, Hao Zhang, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 46

Showing results (441-450 of 455) with videos related to

Sort By:
Pageof 46
ACS Medicinal Chemistry Letters|March 21, 2019
Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481Kenneth M Boy, Jason M Guernon, Dmitry S Zuev, et al.
Journal of Medicinal Chemistry|September 8, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic TherapyAndrew K Dilger, Kumar B Pabbisetty, James R Corte, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Plant Phenomics (Washington, D.C.)|November 15, 2021
Global Wheat Head Detection 2021: An Improved Dataset for Benchmarking Wheat Head Detection MethodsEtienne David, Mario Serouart, Daniel Smith, et al.
Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaTarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
Movement Ecology|April 23, 2024
From little things big things grow: enhancement of an acoustic telemetry network to monitor broad-scale movements of marine species along Australia's east coastAdam Barnett, Fabrice R A Jaine, Stacy L Bierwagen, et al.
Journal of Medicinal Chemistry|March 21, 2019
Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)Scott H Watterson, Qingjie Liu, Myra Beaudoin Bertrand, et al.
Journal of Medicinal Chemistry|October 28, 2021
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic DiseasesPeter T W Cheng, Robert F Kaltenbach, Hao Zhang, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 46